SCHEMBL7581493

SCHEMBL7581493

C1CCN(C2CCN(N3CCCCC3)CC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 9/20 0.48
L3MBTL1 Q9Y468 8/20 0.48
MBTD1 Q05BQ5 5/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
TP53BP1 Q12888 2/20 0.41
L3MBTL4 Q8NA19 1/20 0.41
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26394048 0.82 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL26111928 0.82 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL3313037 0.82
SCHEMBL827994 0.82
SCHEMBL20756261 0.82 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL26109078 0.82 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL28658161 0.80 L3MBTL3 (0.54) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL22048336 0.80 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL13835929 0.80 L3MBTL3 (0.50) L3MBTL3L3MBTL1MBTD1CYP2D6CYP2C19
SCHEMBL13835639 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927192-A1 MODIFIED AMINOACIDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND METHOD FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-07-07 EP claimed
WO-1998011128-A1 MODIFIED AMINOACIDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND METHOD FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1998-03-19 WO claimed
CN-114524912-B Side chain piperidine cation grafted poly biphenyl alkaline membrane and preparation method thereof 北京化工大学 2023-10-27 CN disclosed
EP-1228060-A1 ARYLALKANE, ARYLALKENE AND ARYL AZAALKANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF Boehringer Ingelheim Pharma KG (DE) 2002-08-07 EP disclosed
WO-2001032649-A1 ARYLALKANE, ARYLALKENE AND ARYL AZAALKANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-05-10 WO disclosed